[Skip to Navigation]
Comment & Response
March 15, 2021

Drug-Eluting vs Bare-Metal Stents for Percutaneous Coronary Intervention

Author Affiliations
  • 1Cardiology Department, Sanatorio Otamendi, Buenos Aires, Argentina
  • 2Centro de Estudios en Cardiología Intervencionista, Buenos Aires, Argentina
JAMA Intern Med. 2021;181(7):1012-1013. doi:10.1001/jamainternmed.2021.0030

To the Editor In the last 3 decades, several randomized clinical trials (RCTs) have compared percutaneous coronary interventions (PCIs) with coronary artery bypass grafting (CABG) for the revascularization of patients with coronary artery disease (CAD). In the meta-analysis by Gaudino and colleagues,1 the authors pooled 23 RCTs and concluded that PCI was associated with higher 5-year cardiac as well as noncardiac mortality.

Add or change institution